Captopril 0.8 mg/mL in SyrSpend SF Oral Suspension
Author(s): Allen Loyd V Jr
Issue: Mar/Apr 2019 - Volume 23, Number 2
View All Articles in Issue
Page(s): 148
Download in electronic PDF format for $75
Abstract: A formulation for preparing Captopril 0.8 mg/mL in SyrSpend SF Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.
Related Keywords: Loyd V. Allen Jr., PhD, RPh, captopril, formulation, angiotensin-converting enzyme inhibitor, ACE inhibitor, hypertension, high blood pressure, congestive heart failure, myocardial infarction, heart attack, left ventricular dysfunction, diabetic nephropathy